Paradigm shifts in atherosclerotic renovascular disease: Where are we now?

Journal of the American Society of Nephrology

Volumn 26, Issue 9, 2015, Pages 2074-2080

  Textor, Stephen C ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROTIC RENOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PERFUSION; MITOCHONDRION SWELLING; NEPHROSCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; SODIUM BALANCE; TISSUE INJURY; TISSUE OXYGENATION; ATHEROSCLEROSIS; COMPLICATION; HEMODYNAMICS; ISCHEMIA; KIDNEY; KIDNEY ARTERY STENOSIS; KIDNEY CIRCULATION; MITOCHONDRION; NEPHRITIS; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; VASCULARIZATION;

ATHEROSCLEROSIS; HEMODYNAMICS; HUMANS; ISCHEMIA; KIDNEY; MITOCHONDRIA; NEPHRITIS; OXIDATIVE STRESS; RENAL ARTERY OBSTRUCTION; RENAL CIRCULATION; RENAL INSUFFICIENCY, CHRONIC;

EID: 84940752624     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014121274     Document Type: Article

References (57)

1. Textor SC: Atherosclerotic renal artery stenosis: Overtreated but underrated?JAmSoc Nephrol 19: 656-659, 2008
2. Murphy TP, Soares G, Kim M: Increase in utilization of percutaneous renal artery interventions by medicare beneficiaries, 1996-2000. AJR Am J Roentgenol 183: 561-568, 2004
3. Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, Chew P, Gilbert SJ, Lau J: Effectiveness of management strategies for renal artery stenosis: A systematic review. Ann Intern Med 145: 901-912, 2006
4. Herrmann SM, Saad A, Textor SC: Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). Nephrol Dial Transplant 30: 366-375, 2015
5. Ritchie J, Green D, Chrysochou C, Chalmers N, Foley RN, Kalra PA: High-risk clinical presentations in atherosclerotic renovascular disease: Prognosis and response to renal artery revascularization. Am J Kidney Dis 63: 186-197, 2014
6. Textor SC: Renovascular hypertension: is there still a role for stent revascularization? CurrOpin Nephrol Hypertens 22: 525-530, 2013
7. Textor SC, Misra S, Oderich GS: Percutaneous revascularization for ischemic nephropathy: The past, present, and future. Kidney Int 83: 28-40, 2013
8. De Bruyne B,ManoharanG, PijlsNH, Verhamme K, Madaric J, Bartunek J, Vanderheyden M, Heyndrickx GR: Assessment of renal artery stenosis severity by pressure gradient measurements. J AmColl Cardiol 48: 1851-1855, 2006
9. Drieghe B, Madaric J, Sarno G, Manoharan G, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B: Assessment of renal artery stenosis: Side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur Heart J 29: 517-524, 2008
10. Zhu XY, Urbieta Caceres VH, Favreau FD, Krier JD, Lerman A, Lerman LO: Enhanced endothelial progenitor cell angiogenic potency, present in early experimental renovascular hypertension, deteriorates with disease duration. J Hypertens 29: 1972-1979, 2011
11. Textor SC, Smith-Powell L: Post-stenotic arterial pressures, renal haemodynamics and sodium excretion during graded pressure reduction in conscious rats with one- and two-kidney coarctation hypertension. J Hypertens 6: 311-319, 1988
12. Eirin A, Gloviczki ML, Tang H, Rule AD, Woollard JR, Lerman A, Textor SC, Lerman LO: Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. NephrolDial Transplant 27: 4153-4161, 2012
13. Nath KA, Croatt AJ, Haggard JJ, Grande JP: Renal response to repetitive exposure to heme proteins: Chronic injury induced by an acute insult. Kidney Int 57: 2423-2433, 2000
14. Dzau VJ, Siwek LG, Rosen S, Farhi ER, Mizoguchi H, Barger AC: Sequential renal hemodynamics in experimental benign and malignant hypertension. Hypertension 3: I63-I68, 1981
15. Dustan HP, Humphries AW, Dewolfe VG, Page IH: Normal arterial pressure in patients with renal arterial stenoses. JAMA 187: 1028-1029, 1964
16. Messerli FH, Bangalore S, Makani H, Rimoldi SF,Allemann Y,WhiteCJ, Textor S, Sleight P: Flash pulmonary oedema and bilateral renal artery stenosis: The Pickering syndrome. Eur Heart J 32: 2231-2235, 2011
17. Urbieta-Caceres VH, Zhu XY, Jordan KL, Tang H, Textor K, Lerman A, Lerman LO: Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease. Atherosclerosis 221: 350-358, 2012
18. Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O'Donoghue DJ, Waldek S, Kalra PA: Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 13: 149-157, 2002
19. Kotliar C, Juncos L, Inserra F, de Cavanagh EM, Chuluyan E, Aquino JB, Hita A, Navari C, Sánchez R: Local and systemic cellular immunity in early renal artery atherosclerosis. Clin J Am Soc Nephrol 7: 224-230, 2012
20. Maxwell MH, Marks LS, Lupu AN, Cahill PJ, Franklin SS, Kaufman JJ: Predictive value of renin determinations in renal artery stenosis. JAMA 238: 2617-2620, 1977
21. Simon G, Coleman CC: Captopril-stimulated renal vein reninmeasurements in the diagnosis of atherosclerotic renovascular hypertension. Am J Hypertens 7: 1-6, 1994
22. Basso N, Terragno NA: History about the discovery of the renin-angiotensin system. Hypertension 38: 1246-1249, 2001
23. Wyss JM, Oparil S, Sripairojthikoon W: Neuronal control of the kidney: Contribution to hypertension. Can J Physiol Pharmacol 70: 759-770, 1992
24. Gloviczki ML, Glockner JF, Lerman LO, McKusickMA,Misra S, Grande JP, Textor SC: Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 55: 961-966, 2010
25. Gloviczki ML, Glockner J, Gomez SI, Romero JC, Lerman LO, McKusick M, Textor SC: Comparison of 1.5 and 3 T BOLDMRto study oxygenation of kidney cortex and medulla in human renovascular disease. Invest Radiol 44: 566-571, 2009
26. Pruijm M, Hofmann L, Maillard M, Tremblay S, Glatz N, Wuerzner G, Burnier M, Vogt B: Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men. Hypertension 55: 1116-1122, 2010
27. Warner L, Gomez SI, Bolterman R, Haas JA, Bentley MD, Lerman LO, Romero JC: Regional decreases in renal oxygenation during graded acute renal arterial stenosis: A case for renal ischemia. Am J Physiol Regul Integr Comp Physiol 296: R67-R71, 2009
28. Evans RG,Gardiner BS, Smith DW,O'Connor PM: Intrarenal oxygenation: Unique challenges and the biophysical basis of homeostasis. Am J Physiol Renal Physiol 295: F1259-F1270, 2008
29. HeymanSN, Khamaisi M, Rosen S, Rosenberger C: Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 28: 998-1006, 2008
30. Evans RG, Eppel GA, Michaels S, Burke SL, Nematbakhsh M, Head GA, Carroll JF, O'Connor PM: Multiple mechanisms act to maintain kidney oxygenation during renal ischemia in anesthetized rabbits. Am J Physiol Renal Physiol 298: F1235-F1243, 2010
31. GloviczkiML,Glockner JF, Crane JA,McKusick MA, Misra S, Grande JP, Lerman LO, Textor SC: Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension 58: 1066-1072, 2011
32. Saad A, Herrmann SM, Crane J,Glockner JF, McKusick MA, Misra S, Eirin A, Ebrahimi B, Lerman LO, Textor SC: Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate. Circ Cardiovasc Interv 6: 428-435, 2013
33. Keddis MT, Garovic VD, Bailey KR, Wood CM, Raissian Y, Grande JP: Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: Clinical and histopathological correlates. Nephrol Dial Transplant 25: 3615-3622, 2010
34. Gloviczki ML, Keddis MT, Garovic VD, Friedman H, Herrmann S, McKusick MA, Misra S, Grande JP, Lerman LO, Textor SC: TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol 8: 546-553, 2013
35. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, Lerman LO: Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106: 1165-1171, 2002
36. Chade AR, Rodriguez-Porcel M, Grande JP, ZhuX, SicaV,NapoliC, SawamuraT, TextorSC, Lerman A, Lerman LO: Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 23: 1295-1301, 2003
37. Lavi R, Zhu XY, Chade AR, Lin J, Lerman A, Lerman LO: Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 30: 976-983, 2010
38. Chade AR, Rodriguez-Porcel M, Herrmann J, Zhu X,Grande JP, Napoli C, Lerman A, Lerman LO: Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 15: 958-966, 2004
39. Zhu XY, Chade AR, Rodriguez-Porcel M, Bentley MD, Ritman EL, Lerman A, Lerman LO: Cortical microvascular remodeling in the stenotic kidney: Role of increased oxidative stress. Arterioscler Thromb Vasc Biol 24: 1854-1859, 2004
40. Eirin A, GloviczkiML, Tang H, GösslM, Jordan KL,Woollard JR, Lerman A, Grande JP, Textor SC, Lerman LO: Inflammatory and injury signals released from the post-stenotic human kidney. Eur Heart J 34: 540-548a, 2013
41. Eirin A, Zhang X, Zhu XY, Tang H, Jordan KL, Grande JP, Dietz AB, Lerman A, Textor SC, Lerman LO: Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis. Nephrol Dial Transplant 29: 274-282, 2014
42. Cheng J, Zhou W, Warner GM, Knudsen BE, Garovic VD, Gray CE, Lerman LO, Platt JL, Romero JC, Textor SC, Nath KA, Grande JP: Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 297: F1055-F1068, 2009
43. Rhee EP, Clish CB, Pierce KA, Saad A, Lerman LO, Textor SC: Metabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertension. J Hypertens 33: 836-842, 2015
44. Warner GM, Cheng J, Knudsen BE, Gray CE, Deibel A, Juskewitch JE, Lerman LO, Textor SC, Nath KA, Grande JP: Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension. Am J Physiol Renal Physiol 302: F1455-F1464, 2012
45. Zhang X, Eirin A, Li ZL, Crane JA, Krier JD, Ebrahimi B, Pawar AS, Zhu XY, Tang H, Jordan KL, Lerman A, Textor SC, Lerman LO: Angiotensin blockade has protective effects on the post-stenotic porcine kidney. Kidney Int 84: 767-775, 2013
46. Hackam DG, Duong-HuaML, MamdaniM, Li P, Tobe SW, Spence JD, Garg AX: Angiotensin inhibition in renovascular disease: A population-based cohort study. Am Heart J 156: 549-555, 2008
47. Chrysochou C, Foley RN, Young JF, Khavandi K, Cheung CM, Kalra PA: Dispelling the myth: The use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant 27: 1403-1409, 2012
48. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K,HenrichW,ReidDM,CohenDJ,Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators: Stenting andmedical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 370: 13-22, 2014
49. Chade AR, Krier JD, Rodriguez-PorcelM, Breen JF, McKusick MA, Lerman A, Lerman LO: Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. Am J Physiol Renal Physiol 286: F1079-F1086, 2004
50. Eirin A, Li Z, Zhang X, Krier JD, Woollard JR, Zhu XY, Tang H, Herrmann SM, Lerman A, Textor SC, Lerman LO: A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 60: 1242-1249, 2012
51. Parekh DJ, Weinberg JM, Ercole B, Torkko KC, Hilton W, Bennett M, Devarajan P, Venkatachalam MA: Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol 24: 506-517, 2013
52. Eirin A, Ebrahimi B, Zhang X, Zhu XY, Wollard JR, He Q, Textor SC, Lerman A, Lerman LO: Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease. Cardiovasc Res 103: 461-472, 2014
53. Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, Napoli C, Lerman A, Lerman LO: Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 119: 547-557, 2009
54. Chade AR, Zhu XY, Krier JD, Jordan KL, Textor SC,Grande JP, Lerman A, Lerman LO: Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 28: 1039-1047, 2010
55. Eirin A, Zhu XY, Krier JD, Tang H, Jordan KL, Grande JP, Lerman A, Textor SC, Lerman LO: Adipose tissue-derivedmesenchymal stemcells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 30: 1030-1041, 2012
56. Ebrahimi B, Eirin A, Li Z, Zhu XY, Zhang X, Lerman A, Textor SC, Lerman LO: Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis. PLoS One 8: e67474, 2013
57. Lech M, Gröbmayr R, Ryu M, Lorenz G, Hartter I,Mulay SR, Susanti HE, Kobayashi KS, Flavell RA, Anders HJ: Macrophage phenotype controls long-termAKI outcomes-kidney regeneration versus atrophy. JAmSoc Nephrol 25: 292-304, 2014